{"id":"https://openalex.org/W2186353382","doi":"https://doi.org/10.7573/dic.212288","title":"Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin","display_name":"Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin","publication_year":2015,"publication_date":"2015-11-11","ids":{"openalex":"https://openalex.org/W2186353382","doi":"https://doi.org/10.7573/dic.212288","mag":"2186353382","pmid":"https://pubmed.ncbi.nlm.nih.gov/26633984","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4654596"},"language":"en","primary_location":{"id":"doi:10.7573/dic.212288","doi":"https://doi.org/10.7573/dic.212288","is_oa":true,"landing_page_url":"https://doi.org/10.7573/dic.212288","pdf_url":"https://www.drugsincontext.com/wp-content/uploads/2015/11/dic.212288-COI.pdf","source":{"id":"https://openalex.org/S2764578562","display_name":"Drugs in Context","issn_l":"1740-4398","issn":["1740-4398","1745-1981"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311745","host_organization_name":"BioExcel Publishing Ltd","host_organization_lineage":["https://openalex.org/P4310311745"],"host_organization_lineage_names":["BioExcel Publishing Ltd"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in Context","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.drugsincontext.com/wp-content/uploads/2015/11/dic.212288-COI.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082525611","display_name":"Andrew Ahmann","orcid":"https://orcid.org/0000-0002-4544-5404","observed_orcids":["https://orcid.org/0000-0002-4544-5404"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew Ahmann","raw_affiliation_strings":["Oregon Health & Science University, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5082525611"],"corresponding_institution_ids":["https://openalex.org/I165690674"],"apc_list":{"value":1550,"currency":"GBP","value_usd":1901},"apc_paid":{"value":1550,"currency":"GBP","value_usd":1901},"fwci":1.1669,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.77197268,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"4","issue":"4","first_page":"1","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9610000252723694},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9269999861717224},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8849999904632568},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8479999899864197},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9200000166893005},{"id":"https://openalex.org/keywords/urinary-tract-infection","display_name":"urinary tract infection","score":0.9309999942779541},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8450000286102295},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9380000233650208}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.9769573211669922},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8610173463821411},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.7018024921417236},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6565924882888794},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5856311917304993},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5713139772415161},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.56488436460495},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4879314601421356},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48123741149902344},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.45131659507751465},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3902606964111328},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35956573486328125}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.7573/dic.212288","doi":"https://doi.org/10.7573/dic.212288","is_oa":true,"landing_page_url":"https://doi.org/10.7573/dic.212288","pdf_url":"https://www.drugsincontext.com/wp-content/uploads/2015/11/dic.212288-COI.pdf","source":{"id":"https://openalex.org/S2764578562","display_name":"Drugs in Context","issn_l":"1740-4398","issn":["1740-4398","1745-1981"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311745","host_organization_name":"BioExcel Publishing Ltd","host_organization_lineage":["https://openalex.org/P4310311745"],"host_organization_lineage_names":["BioExcel Publishing Ltd"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in Context","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3642095","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4654596","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:26633984","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26633984","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in context","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4654596","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4654596/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs Context","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:6611713af81d4ee2bc0c2a843afb3900","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/6611713af81d4ee2bc0c2a843afb3900","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drugs in Context, Pp 1-7 (2015)","raw_type":"article"},{"id":"mag:2341460103","doi":null,"is_oa":false,"landing_page_url":"https://www.drugsincontext.com/wp-content/uploads/2015/11/dic.212288.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.7573/dic.212288","doi":"https://doi.org/10.7573/dic.212288","is_oa":true,"landing_page_url":"https://doi.org/10.7573/dic.212288","pdf_url":"https://www.drugsincontext.com/wp-content/uploads/2015/11/dic.212288-COI.pdf","source":{"id":"https://openalex.org/S2764578562","display_name":"Drugs in Context","issn_l":"1740-4398","issn":["1740-4398","1745-1981"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311745","host_organization_name":"BioExcel Publishing Ltd","host_organization_lineage":["https://openalex.org/P4310311745"],"host_organization_lineage_names":["BioExcel Publishing Ltd"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs in Context","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2186353382.pdf"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1559592680","https://openalex.org/W1604180328","https://openalex.org/W1613501644","https://openalex.org/W1847388060","https://openalex.org/W1955935325","https://openalex.org/W2017508478","https://openalex.org/W2024372370","https://openalex.org/W2028371970","https://openalex.org/W2030311010","https://openalex.org/W2041205525","https://openalex.org/W2042661216","https://openalex.org/W2048260881","https://openalex.org/W2057595002","https://openalex.org/W2095682936","https://openalex.org/W2100796772","https://openalex.org/W2101344933","https://openalex.org/W2103829708","https://openalex.org/W2105660444","https://openalex.org/W2107999129","https://openalex.org/W2109728760","https://openalex.org/W2111876001","https://openalex.org/W2116974726","https://openalex.org/W2117505171","https://openalex.org/W2132690994","https://openalex.org/W2138173919","https://openalex.org/W2141800817","https://openalex.org/W2146264128","https://openalex.org/W2146681672","https://openalex.org/W2148717983","https://openalex.org/W2160088494","https://openalex.org/W2167793764","https://openalex.org/W2172193326"],"related_works":["https://openalex.org/W2341460103","https://openalex.org/W2074352721","https://openalex.org/W2326369374","https://openalex.org/W1847388060","https://openalex.org/W1874982603","https://openalex.org/W4414967616","https://openalex.org/W4382345224","https://openalex.org/W2801822172","https://openalex.org/W3171629882","https://openalex.org/W2098611244"],"abstract_inverted_index":{"Type":[0],"2":[1,31],"diabetes":[2],"mellitus":[3],"(T2DM)":[4],"management":[5],"is":[6],"complex,":[7],"with":[8,16,41,54,87,94,119,133,146,173,199],"few":[9,193],"patients":[10,86,218],"successfully":[11],"achieving":[12],"recommended":[13],"glycemic":[14,89,225],"targets":[15],"monotherapy,":[17],"most":[18],"progressing":[19],"to":[20,82,104,126,188,208],"combination":[21,53,141],"therapy,":[22],"and":[23,110,130,156,167],"many":[24],"eventually":[25],"requiring":[26],"insulin.":[27,62],"Sodium":[28],"glucose":[29],"cotransporter":[30],"(SGLT2)":[32],"inhibitors":[33],"are":[34],"an":[35,42,77],"emerging":[36],"class":[37,57],"of":[38,45,58,75,149,203],"antidiabetes":[39,59],"agents":[40],"insulin-independent":[43],"mechanism":[44],"action,":[46,204],"making":[47],"them":[48],"suitable":[49],"for":[50],"use":[51],"in":[52,85,108,113,137,153,180,191,217],"any":[55],"other":[56],"agents,":[60],"including":[61],"This":[63,140],"review":[64],"evaluates":[65],"a":[66,99,213],"78-week,":[67],"randomized,":[68],"double-blind,":[69],"placebo-controlled":[70],"trial":[71],"investigating":[72],"the":[73,154,160,181],"impact":[74],"empagliflozin,":[76],"SGLT2":[78,174],"inhibitor,":[79],"as":[80],"add-on":[81],"basal":[83,92,105,209,220],"insulin":[84,106,210,221],"inadequate":[88],"control":[90,226],"on":[91,103,207,219],"insulin,":[93],"or":[95],"without":[96,227],"metformin":[97],"and/or":[98],"sulfonylurea.":[100],"Empagliflozin":[101,121],"added":[102,206],"resulted":[107],"significant":[109],"sustained":[111,134],"reductions":[112],"glycated":[114],"hemoglobin":[115],"(HbA1c)":[116],"levels":[117,148],"compared":[118],"placebo.":[120],"has":[122],"previously":[123],"been":[124],"shown":[125],"induce":[127],"weight":[128,135,228],"loss,":[129],"was":[131,143],"associated":[132,172],"loss":[136],"this":[138],"study.":[139],"therapy":[142],"well":[144],"tolerated,":[145],"similar":[147],"hypoglycemic":[150],"adverse":[151],"events":[152,186],"empagliflozin":[155,182,205],"placebo":[157],"groups":[158],"over":[159],"78-week":[161],"treatment":[162,189,215],"period.":[163],"Urinary":[164],"tract":[165],"infections":[166],"genital":[168],"infections,":[169],"side":[170],"effects":[171],"inhibitors,":[175],"were":[176],"reported":[177],"more":[178],"commonly":[179],"group;":[183],"however,":[184],"such":[185],"led":[187],"discontinuation":[190],"very":[192],"patients.":[194],"These":[195],"findings":[196],"suggest":[197],"that,":[198],"their":[200],"complementary":[201],"mechanisms":[202],"may":[211],"be":[212],"useful":[214],"option":[216],"who":[222],"need":[223],"additional":[224],"gain.":[229]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}